Assessing lead time of selected ovarian cancer biomarkers
December 31st, 2009
Concentrations of the biomarkers CA125, human epididymis protein 4 , and mesothelin began to rise 3 years before clinical diagnosis of ovarian cancer, according to a new study published online December 30 in the Journal of the National Cancer Institute .
Original post by Physics Blog
(click on the author/publication link above to see full post)